FindTrial
Sign In

Multicentre study on the morbidity of hyperornithine - hyperaminemia - isocitrullinuria syndrome

Multicentre study on the morbidity of hyperornithine - hyperaminemia - isocitrullinuria syndrome in China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047878
Enrollment
Unknown
Registered
2021-06-27
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperornithine - hyperaminemia - isocitrullinuria syndrome

Interventions

case series:NO

Sponsors

Department of Pediatrics, The Seventh Medical Center, PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. The parents read the instructions for the subjects, agreed to the treatment and signed the written informed consent; 2. Clinical diagnosis and treatment of suspected HHHS.

Exclusion criteria

Exclusion criteria: Unable to comply with test requirements.

Design outcomes

Primary

MeasureTime frame
blood ammonia;Ornithine concentration;Isotype citrulline concentration;—

Countries

China

Contacts

Public ContactFeng Zhichun

Department of Pediatrics, The Seventh Medical Center, PLA General Hospital

zhjfengzc@126.com+86 13321154215

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026